Apotex Health Corp (APTX.TO) — the peer cohort

As of 2026-09-18 — scores re-bake nightly. Cohort = shared Closelook index membership first, then sector. Diary readings, not advice.

Apotex Health Corp ranks 11 of 11 in its cohort on the Closelook composite (48/100) — the cohort is led by BB Biotech AG at 74/100.

NameCompositeMomentumQualityValuationSignalOff 52w high
APTX.TO Apotex Health Corp 48 63 55 50
ALKS Alkermes Plc 53 75 51 23 info 16.1%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock 53 85 56 43 ok 5.1%
BHC.TO Bausch Health Companies Inc 53 49 69 84 info 28.5%
ALM.MC Almirall S.A. 52 25 44 67 warn 23.2%
FAGR.BR Fagron NV 51 40 53 61 info 12.3%
TAK Takeda Pharmaceutical Co Ltd ADR 50 70 37 81 ok 0.3%
BION.SW BB Biotech AG 74 73 95 81 info 8.4%
ARGX.BR Argen-X 64 78 73 28 ok 6.2%
ARGX argenx NV ADR 64 78 72 27 ok 7.2%
LLY Eli Lilly and Company 64 68 90 29 watch 10.8%

Scores are relative readings across the Closelook coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.

FAQ · from the current data · as of 2026-09-18

Quick answers

Who are Apotex Health Corp's peers in the Closelook universe?

The cohort is drawn from shared Closelook index membership first, then sector: Alkermes Plc (ALKS), Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX), Bausch Health Companies Inc (BHC.TO), Almirall S.A. (ALM.MC), Fagron NV (FAGR.BR), Takeda Pharmaceutical Co Ltd ADR (TAK), BB Biotech AG (BION.SW), Argen-X (ARGX.BR) and others.

How does APTX.TO score against its peers?

Apotex Health Corp's composite reads 48/100, ranking 11 of 11 in its cohort as of 2026-09-18; the cohort's highest composite is BB Biotech AG at 74/100. Closelook scores are research diary readings, not ratings or advice.

Related in the Closelook universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelook score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.